PHARMACEUTICAL COMPOSITION FOR USE IN THE PROPHYLACTIC AND/OR THERAPEUTIC TREATMENT OF L-DOPA-INDUCED DYSKINESIA

Patent number:

US11337985B2

No items found.

Pharmaceutical composition for use in the prophylactic and/or therapeutic treatment of dyskinesias induced by L-DOPA. The present invention relates to the pharmaceutical field, more particularly to the use of Rho kinase inhibitors for treating or preventing dyskinesias induced by L-DOPA.

Countries:

Spain

Regions:

Galicia

Centers:

UNIVERSIDAD DE SANTIAGO DE COMPOSTELA

Other entities:

Sectors:

Health

Subsectors:

TRL Level:

TRL 4 – technology validated in lab

BRL Level:

PDF Link:

Download here

Video Link:

Watch it here

Sustainable Development Goal:

Applications

The results that are presented in this document demonstrate that inhibition of the RhoA/Rho kinase (ROCK) pathway makes it possible to treat and/or prevent the dyskinesias that may be caused by chronic treatment with L-DOPA, administered to patients with Parkinson's disease.

Comments

Other related patents

Health

Biotin & Thiamine: A novel therapeutic strategy for Huntington’s Disease

Countries

Spain

Health

Treatment of Charcot-Marie-Tooth disease

Countries

Spain

Health

BIOMARKERS AND METHOD FOR PREDICTING OR FORECASTING RESPONSE TO TREATMENT WITH BRAF AND MEK INHIBITORS (BRAFi + MEKi) IN PATIENTS WITH METASTATIC MELANOMA

Countries

Spain

Get back to patents directory